Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20161205031252N12Phase 3Completed
Phase 3 trial of ketamine, magnesium sulfate and propofol in None (3 arms), sponsored by Qom University of Medical Sciences. Primary endpoint: Sedative effect comparison. Started Jan 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20161205031252N12.